Identification and Validation of an E2F-Related Gene Signature for Predicting Recurrence-Free Survival in Human Prostate Cancer

Five cohorts from The Cancer Genome Atlas and Gene Expression Omnibus databases were used to perform gene set variation analysis between nonrecurrent and recurrent prostate cancer patients.